News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
729,030 Results
Type
Article (41771)
Company Profile (273)
Press Release (686972)
Multimedia
Podcasts (88)
Webinars (20)
Section
Business (205525)
Career Advice (2042)
Deals (35714)
Drug Delivery (122)
Drug Development (81643)
Employer Resources (173)
FDA (16522)
Job Trends (15068)
News (348019)
Policy (32969)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2597)
Accelerated approval (42)
Adcomms (25)
Allergies (160)
Alliances (49844)
ALS (192)
Alzheimer's disease (1741)
Antibody-drug conjugate (ADC) (366)
Approvals (16840)
Artificial intelligence (592)
Autoimmune disease (221)
Automation (50)
Bankruptcy (362)
Best Places to Work (11665)
BIOSECURE Act (20)
Biosimilars (203)
Biotechnology (178)
Bladder cancer (177)
Brain cancer (63)
Breast cancer (684)
Cancer (5279)
Cardiovascular disease (443)
Career advice (1729)
Career pathing (39)
CAR-T (296)
CDC (53)
Celiac Disease (2)
Cell therapy (791)
Cervical cancer (41)
Clinical research (70337)
Collaboration (1877)
Company closure (4)
Compensation (1253)
Complete response letters (69)
COVID-19 (2743)
CRISPR (98)
C-suite (963)
Cystic fibrosis (147)
Data (7014)
Decentralized trials (3)
Denatured (27)
Depression (153)
Dermatology (57)
Diabetes (550)
Diagnostics (6829)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (290)
Drug pricing (193)
Drug shortages (30)
Duchenne muscular dystrophy (265)
Earnings (91218)
Editorial (60)
Employer branding (21)
Employer resources (152)
Events (118566)
Executive appointments (1029)
FDA (19922)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1602)
Gene editing (210)
Generative AI (51)
Gene therapy (650)
GLP-1 (1024)
Government (4705)
Grass and pollen (6)
Guidances (396)
Healthcare (18951)
HIV (73)
Huntington's disease (51)
IgA nephropathy (91)
Immunology and inflammation (269)
Immuno-oncology (79)
Indications (155)
Infectious disease (3055)
Inflammatory bowel disease (199)
Inflation Reduction Act (14)
Influenza (128)
Intellectual property (272)
Interviews (316)
IPO (16669)
IRA (50)
Job creations (3725)
Job search strategy (1442)
JPM (59)
Kidney cancer (18)
Labor market (92)
Layoffs (555)
Leadership (34)
Legal (8047)
Liver cancer (97)
Longevity (28)
Lung cancer (710)
Lymphoma (405)
Machine learning (52)
Management (59)
Manufacturing (914)
MASH (177)
Medical device (13872)
Medtech (13949)
Mergers & acquisitions (20192)
Metabolic disorders (1412)
mRNA (173)
Multiple sclerosis (172)
NASH (18)
Neurodegenerative disease (380)
Neuropsychiatric disorders (95)
Neuroscience (3121)
Neurotech (1)
NextGen: Class of 2026 (6536)
Non-profit (4541)
Now hiring (73)
Obesity (663)
Opinion (276)
Ovarian cancer (183)
Pain (226)
Pancreatic cancer (252)
Parkinson's disease (335)
Partnered (34)
Patents (549)
Patient recruitment (581)
Peanut (60)
People (59433)
Pharmaceutical (61)
Pharmacy benefit managers (31)
Phase 1 (21918)
Phase 2 (30948)
Phase 3 (23073)
Pipeline (7022)
Policy (304)
Postmarket research (2585)
Preclinical (9287)
Press Release (64)
Prostate cancer (275)
Psychedelics (49)
Radiopharmaceuticals (303)
Rare diseases (981)
Real estate (6025)
Recruiting (70)
Regulatory (25050)
Reports (54)
Research institute (2419)
Resumes & cover letters (355)
Rett syndrome (32)
RNA editing (17)
RSV (85)
Schizophrenia (160)
Series A (267)
Series B (198)
Service/supplier (11)
Sickle cell disease (106)
Special edition (22)
Spinal muscular atrophy (164)
Sponsored (46)
Startups (3638)
State (2)
Stomach cancer (18)
Supply chain (118)
Tariffs (84)
The Weekly (59)
Vaccines (1058)
Venture capital (98)
Weight loss (424)
Women's health (108)
Worklife (19)
Date
Today (179)
Last 7 days (689)
Last 30 days (2826)
Last 365 days (30161)
2026 (7743)
2025 (30200)
2024 (35258)
2023 (40115)
2022 (51219)
2021 (55796)
2020 (54213)
2019 (46699)
2018 (35131)
2017 (32233)
2016 (31648)
2015 (37714)
2014 (31516)
2013 (26520)
2012 (28783)
2011 (29508)
2010 (27558)
Location
Africa (753)
Alabama (89)
Alaska (7)
Arizona (329)
Arkansas (13)
Asia (40481)
Australia (6469)
California (12209)
Canada (3492)
China (1218)
Colorado (519)
Connecticut (518)
Delaware (364)
Europe (85621)
Florida (1845)
Georgia (392)
Hawaii (3)
Idaho (63)
Illinois (955)
India (84)
Indiana (567)
Iowa (22)
Japan (483)
Kansas (129)
Kentucky (44)
Louisiana (38)
Maine (73)
Maryland (1480)
Massachusetts (8709)
Michigan (345)
Minnesota (672)
Mississippi (6)
Missouri (138)
Montana (33)
Nebraska (29)
Nevada (135)
New Hampshire (82)
New Jersey (3259)
New Mexico (28)
New York (3211)
North Carolina (1548)
North Dakota (8)
Northern California (6037)
Ohio (361)
Oklahoma (22)
Oregon (41)
Pennsylvania (2466)
Puerto Rico (25)
Rhode Island (50)
South America (1122)
South Carolina (74)
South Dakota (1)
Southern California (4789)
Tennessee (198)
Texas (1914)
United States (43222)
Utah (365)
Vermont (1)
Virginia (291)
Washington D.C. (81)
Washington State (979)
West Virginia (4)
Wisconsin (117)
Wyoming (2)
729,030 Results for "gne india inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ultragenyx Announces FDA Clearance of Investigational New Drug (IND) Application for UX016, a Sialic Acid Prodrug for the Treatment of GNE Myopathy
March 30, 2026
·
7 min read
Press Releases
New England Biolabs® opens subsidiary in India
March 5, 2026
·
2 min read
Press Releases
Bavarian Nordic and Serum Institute of India Expand Strategic Partnership with Chikungunya Vaccine Manufacturing Agreement
March 11, 2026
·
4 min read
Press Releases
Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization
March 25, 2026
·
5 min read
Press Releases
Cambridge Cognition Partners With Ivory to Scale Early Cognitive Screening With CANTAB Pathway™ in India
February 18, 2026
·
6 min read
Press Releases
IBA and Shreeji sign multi‑site agreement for four cyclotrons to expand PET radiopharmaceutical manufacturing across India
February 19, 2026
·
3 min read
Press Releases
Cambridge Isotope Laboratories, Inc. and Chemtatva Chiral Solutions Pvt. Ltd. to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India
October 28, 2025
·
3 min read
Press Releases
Bio-Thera Solutions Announces Further Expansion of Partnership with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), through Exclusive Commercialization and License Agreement in India
March 23, 2026
·
5 min read
Press Releases
Kashiv BioSciences and Intas Pharmaceuticals Sign an Exclusive Licensing and Supply Agreement for Complex Peptide Product in Europe, the UK & India
February 10, 2026
·
3 min read
Press Releases
Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement
January 1, 2026
·
7 min read
1 of 72,903
Next
